CNTB
Connect Biopharma Holdings
CNTB
CNTB
25 hedge funds and large institutions have $16.4M invested in Connect Biopharma Holdings in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
75% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 12
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$581K | |
| 2 | +$24.2K | |
| 3 | +$21.1K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.67K |
| 5 |
SA
SRH Advisors
Salina,
Kansas
|
+$2K |
Top Sellers
| 1 | -$637K | |
| 2 | -$591K | |
| 3 | -$516K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$357K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$218K |